Health Care Reform Is Healthy

Stock quotes in this article:IHF, VHT, IHI 

NEW YORK (TheStreet) -- President Obama is putting pressure on Congress to finalize health care reform legislation before the end of the year, and this is likely to make the health care and medical sectors even more compelling.

The sector has been attractive to investors because of several factors: The elderly population is growing; there has been an increase in diseases and cancer rates; and Americans generally want to live longer and healthier lives. In addition, health care companies have seen continuous year-over-year revenue growth.

The proposed reform is expected to further accentuate the sector's appeal by increasing accessibility to prescription drugs and turning tens of millions of previously uninsured people to into health care customers.

You'd think that those affiliated with the industry would be smiling from ear to ear, but they're not. Opponents of the legislation are against the idea of a government-run insurance program, and drug makers are upset over the billions of dollars in rebates they will have to fork over to the government over the next decade. Additionally, medical device providers are upset because they will be forced to pay a 2.5% tax to the government on all of their products.

At the end of the day though, there is hope for the sector, in particular drug makers and hospitals. Lobbyists for Big Pharma have managed to include an $80 billion rebate agreement in the reform, while also successfully winning a fight that would have required some of its largest players to pay back another $106 billion in additional rebates over 10 years.

TheStreet Premium Services    For Personal Service: 877-471-2967

Jim Cramer
Jim Cramer's Action Alerts PLUS:
Trade right alongside a Wall Street pro — enjoy access to his Charitable Trust portfolio and be sent trade alerts BEFORE he makes a move. Learn More
New: ETF Profits
ETF Profits:
Get money-making ideas from the hottest investment vehicle on the planet. Our experts show you how to play various ETF sectors to help pump-up your portfolio. Learn More
OptionsProfits
OptionsProfits:
Get 50+ trade ideas a week from the industry's top options experts. Plus — exclusive commentary on market trends and essential trading tools. Learn More
Doug Kass
Real Money:
Our team of professional Wall Street Pros — including Jim Cramer, Doug Kass, and Nicholas Vardy — delivers intelligent analysis, timely trade ideas, and colorful commentary. Learn More
Stocks Under $10
Stocks Under $10:
Break into the market with small- and mid-cap stocks... all $10 or less! David Peltier tells you exactly which low-priced stocks he's buying and selling. Learn More
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
blog comments powered by Disqus
Dow Jones S&P 500 NASDAQ 10-Year Note
12,772.96 1,340.83 2,905.90 19.81
Oil *
117.29
DOWN
117.50
DOWN
11.12
DOWN
21.33
DOWN
0.66
10 Yr
1.98%
SPDR Gold
167.41
-0.91%
-0.82%
-0.73%
-3.22%
Data delayed 20 minutes

Top Stories and Tools

Brokerage Partners

After the Bell

Before the Bell

Booyah! Newsletter

ETF Daily

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

We respect your privacy.
Podcasts

Connect with TheStreet